Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionCapital Fund Management S.a.
Latest Disclosed Ownership122,934 shares
Latest Disclosed Value $ 54,894,948
Capital Fund Management S.a. ownership in VRTX / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - Capital Fund Management S.a. filed a 13F-HR form disclosing ownership of 122,934 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $54,894,948 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 13, 2024 disclosing 0 shares of Vertex Pharmaceuticals Incorporated. The current value of the position is $54,304,865 USD.

Capital Fund Management S.a. has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS INC COM VERTEX PHARMACEUTICALS INC COM 92532F100 122,934 122,934 54,895 0.2481
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -61,530 -100.00 0 -100.00
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 61,530 61,530 25,720 0.0744
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -17,577 -100.00 0 -100.00
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17,577 -36,888 -67.73 3,777 -70.66 0.0417
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 54,465 -13,651 -20.04 12,872 -30.55 0.1214
2020-11-13 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 68,116 48,783 252.33 18,536 230.27 0.2289
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 19,333 19,333 5,613 0.0891
2020-05-13 2020-03-31 13F Vertex Pharmaceuticals COM 92532F100 0 -10,432 -100.00 0 -100.00
2020-02-13 2019-12-31 13F Vertex Pharmaceuticals COM 92532F100 10,432 10,432 2,284 0.0180
2019-08-12 2019-06-30 13F Vertex Pharmaceuticals COM 92532F100 0 -13,413 -100.00 0 -100.00
2019-05-13 2019-03-31 13F/A-1 Vertex Pharmaceuticals COM 92532F100 13,413 -62,323 -82.29 2,467 -80.34 0.0221
2019-05-13 2019-03-31 13F Vertex Pharmaceuticals COM 92532F100 75,736 0 12,550
2019-02-13 2018-12-31 13F Vertex Pharmaceuticals COM 92532F100 75,736 6,072 8.72 12,550 -6.53 0.1110
2018-11-14 2018-09-30 13F Vertex Pharmaceuticals COM 92532F100 69,664 -43,864 -38.64 13,427 -30.41 0.0732
2018-08-14 2018-06-30 13F Vertex Pharmaceuticals COM 92532F100 113,528 62,300 121.61 19,295 131.11 0.1007
2018-05-15 2018-03-31 13F Vertex Pharmaceuticals COM 92532F100 51,228 -167,638 -76.59 8,349 -74.54 0.0501
2018-02-09 2017-12-31 13F Vertex Pharmaceuticals COM 92532F100 218,866 56,700 34.96 32,799 33.03 0.1808
2017-11-13 2017-09-30 13F Vertex Pharmaceuticals COM 92532F100 162,166 118,400 270.53 24,656 337.16 0.1772
2017-08-10 2017-06-30 13F Vertex Pharmaceuticals COM 92532F100 43,766 6,487 17.40 5,640 38.37 0.0455
2017-05-03 2017-03-31 13F Vertex Pharmaceuticals COM 92532F100 37,279 37,279 4,076 0.0340
2017-02-08 2016-12-31 13F Vertex Pharmaceuticals COM 92532F100 0 -63,578 -100.00 0 -100.00
2016-10-31 2016-09-30 13F Vertex Pharmaceuticals COM 92532F100 63,578 50,779 396.74 5,545 403.63 0.0509
2016-07-27 2016-06-30 13F Vertex Pharmaceuticals COM 92532F100 12,799 12,799 0.00 1,101 0.0103
2016-05-02 2016-03-31 13F Vertex Pharmaceuticals COM 92532F100 0 -195,893 -100.00 0 -100.00
2016-01-28 2015-12-31 13F Vertex Pharmaceuticals COM 92532F100 195,893 -83,252 -29.82 24,649 -15.21 0.2536
2015-10-27 2015-09-30 13F Vertex Pharmaceuticals COM 92532F100 279,145 247,180 773.28 29,070 636.51 0.3250
2015-07-28 2015-06-30 13F Vertex Pharmaceuticals COM 92532F100 31,965 31,965 0.00 3,947 0.0501
2015-01-28 2014-12-31 13F Vertex Pharmaceuticals COM 92532F100 0 -10,994 -100.00 0 -100.00
2014-10-31 2014-09-30 13F Vertex Pharmaceuticals COM 92532F100 10,994 -3,797 -25.67 1,235 4.57 0.0138
2013-07-31 2013-06-30 13F Vertex Pharmaceuticals COM 92532F100 14,791 14,791 1,181 0.0180
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Call 17,500 6,085 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS COM Call 14,700 -35.81 4,245 -35.97 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 22,900 6,630 n/a n/a n/a
2020-08-13 2020-06-30 13F Vertex Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F Vertex Pharmaceuticals COM Call 11,700 631.25 2,784 695.43 n/a n/a n/a
2020-02-13 2019-12-31 13F Vertex Pharmaceuticals COM Call 1,600 350 n/a n/a n/a
2018-05-15 2018-03-31 13F Vertex Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F Vertex Pharmaceuticals COM Call 2,900 -47.27 435 -47.97 n/a n/a n/a
2017-11-13 2017-09-30 13F Vertex Pharmaceuticals COM Call 5,500 836 n/a n/a n/a
2015-01-28 2014-12-31 13F Vertex Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-10-31 2014-09-30 13F Vertex Pharmaceuticals COM Call 4,500 50.00 505 122.47 n/a n/a n/a
2014-01-31 2013-12-31 13F Vertex Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-10-31 2013-09-30 13F Vertex Pharmaceuticals COM Call 3,000 -93.72 227 -94.05 n/a n/a n/a
2013-07-31 2013-06-30 13F Vertex Pharmaceuticals COM Call 47,800 3,818 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS COM Put 11,500 5,348 n/a n/a n/a
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 13,500 5,643 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Put 41,300 14,362 n/a n/a n/a
2020-08-13 2020-06-30 13F Vertex Pharmaceuticals COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F Vertex Pharmaceuticals COM Put 6,500 1,547 n/a n/a n/a
2018-05-15 2018-03-31 13F Vertex Pharmaceuticals COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F Vertex Pharmaceuticals COM Put 2,500 -46.81 375 -47.55 n/a n/a n/a
2017-11-13 2017-09-30 13F Vertex Pharmaceuticals COM Put 4,700 715 n/a n/a n/a
2015-01-28 2014-12-31 13F Vertex Pharmaceuticals COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-10-31 2014-09-30 13F Vertex Pharmaceuticals COM Put 1,800 -94.59 202 -92.41 n/a n/a n/a
2013-07-31 2013-06-30 13F Vertex Pharmaceuticals COM Put 33,300 2,660 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.